Home - Products - Others - Other Targets - 8-Fluoro-1345-tetrahydro-6H-azepino[543-cd]indol-6-one

8-Fluoro-1345-tetrahydro-6H-azepino[543-cd]indol-6-one

CAS No. 1408282-26-7

8-Fluoro-1345-tetrahydro-6H-azepino[543-cd]indol-6-one( —— )

Catalog No. M19779 CAS No. 1408282-26-7

8-Fluoro-1345-tetrahydro-6H-azepino[543-cd]indol-6-one

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 48 In Stock
10MG 68 In Stock
25MG 115 In Stock
50MG 173 In Stock
100MG 258 In Stock
200MG 388 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    8-Fluoro-1345-tetrahydro-6H-azepino[543-cd]indol-6-one
  • Note
    Research use only, not for human use.
  • Brief Description
    8-Fluoro-1345-tetrahydro-6H-azepino[543-cd]indol-6-one
  • Description
    8-Fluoro-1345-tetrahydro-6H-azepino[543-cd]indol-6-one
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1408282-26-7
  • Formula Weight
    204.2
  • Molecular Formula
    C11H9FN2O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    Fc1cc2C(=O)NCCc3c[nH]c(c1)c23
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Bromodeoxyuridine (B...

    Bromodeoxyuridine (BrdU) is a nucleoside analog that competes with thymidine for incorporation into DNA, and used in the detection of proliferating cells.

  • Propargyl-PEG5-Ms

    Propargyl-PEG5-Ms is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

  • 8-Hydroxyguanosine

    8-hydroxyguanosine (8-OHG) is a marker for measuring the rate of oxidative damage to nucleic acids and lipids.The concentration of 8-OHG in CSF in Parkinson's disease (PD) patients is approximately three-fold that in controls. The concentration of 8-OHG in CSF decreased significantly with the duration of disease. However, the concentration of 8-OHG in serum was not significantly altered in PD patients compared to that in controls.